Sysmex Corporation (SSMXF)
USD 16.24
(2.78%)
USD 16.24
(2.78%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 164.11 Billion JPY | 17.2% |
| 2023 | 140.03 Billion JPY | 13.69% |
| 2022 | 123.16 Billion JPY | 20.15% |
| 2021 | 102.5 Billion JPY | -1.93% |
| 2020 | 104.52 Billion JPY | 4.18% |
| 2019 | 100.32 Billion JPY | 1.55% |
| 2018 | 98.79 Billion JPY | 9.68% |
| 2017 | 90.07 Billion JPY | -4.31% |
| 2016 | 94.13 Billion JPY | 15.35% |
| 2015 | 81.6 Billion JPY | -1.5% |
| 2014 | 82.85 Billion JPY | 23.31% |
| 2013 | 67.19 Billion JPY | 5.17% |
| 2012 | 63.88 Billion JPY | 6.45% |
| 2011 | 60.01 Billion JPY | 3.5% |
| 2010 | 57.98 Billion JPY | 3.79% |
| 2009 | 55.87 Billion JPY | 11.09% |
| 2008 | 50.29 Billion JPY | 12.19% |
| 2007 | 44.82 Billion JPY | 10.89% |
| 2006 | 40.42 Billion JPY | 15.41% |
| 2005 | 35.02 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 41.46 Billion JPY | 2.83% |
| 2024 Q1 | 37.13 Billion JPY | -6.1% |
| 2024 Q2 | 40.32 Billion JPY | 8.6% |
| 2024 Q4 | 46.13 Billion JPY | 11.26% |
| 2024 FY | 165.2 Billion JPY | 17.97% |
| 2023 Q4 | 39.54 Billion JPY | 12.64% |
| 2023 Q2 | 33.48 Billion JPY | 4.93% |
| 2023 Q1 | 31.9 Billion JPY | -10.53% |
| 2023 FY | 140.03 Billion JPY | 13.69% |
| 2023 Q3 | 35.1 Billion JPY | 4.85% |
| 2022 Q2 | 29.27 Billion JPY | 9.09% |
| 2022 Q4 | 35.66 Billion JPY | 13.58% |
| 2022 FY | 123.16 Billion JPY | 20.15% |
| 2022 Q1 | 26.83 Billion JPY | -9.99% |
| 2022 Q3 | 31.39 Billion JPY | 7.25% |
| 2021 Q2 | 23.61 Billion JPY | -0.2% |
| 2021 Q1 | 23.66 Billion JPY | -13.1% |
| 2021 FY | 102.5 Billion JPY | -1.93% |
| 2021 Q4 | 29.81 Billion JPY | 17.31% |
| 2021 Q3 | 25.41 Billion JPY | 7.6% |
| 2020 Q2 | 24.14 Billion JPY | -5.65% |
| 2020 Q1 | 25.58 Billion JPY | -5.54% |
| 2020 Q3 | 27.55 Billion JPY | 14.14% |
| 2020 Q4 | 27.23 Billion JPY | -1.17% |
| 2020 FY | 104.52 Billion JPY | 4.18% |
| 2019 Q3 | 25.2 Billion JPY | 4.07% |
| 2019 FY | 100.32 Billion JPY | 1.55% |
| 2019 Q4 | 27.08 Billion JPY | 7.46% |
| 2019 Q2 | 24.22 Billion JPY | 1.74% |
| 2019 Q1 | 23.8 Billion JPY | -15.58% |
| 2018 FY | 98.79 Billion JPY | 9.68% |
| 2018 Q4 | 28.2 Billion JPY | 17.07% |
| 2018 Q3 | 24.09 Billion JPY | 0.11% |
| 2018 Q2 | 24.06 Billion JPY | 7.25% |
| 2018 Q1 | 22.43 Billion JPY | -9.1% |
| 2017 Q2 | 22.33 Billion JPY | 8.77% |
| 2017 Q1 | 20.53 Billion JPY | -16.87% |
| 2017 Q3 | 22.51 Billion JPY | 0.81% |
| 2017 FY | 90.07 Billion JPY | -4.31% |
| 2017 Q4 | 24.68 Billion JPY | 9.63% |
| 2016 Q4 | 24.7 Billion JPY | 9.24% |
| 2016 Q2 | 21.83 Billion JPY | -3.55% |
| 2016 Q1 | 22.63 Billion JPY | 1.61% |
| 2016 FY | 94.13 Billion JPY | 15.35% |
| 2016 Q3 | 22.61 Billion JPY | 3.57% |
| 2015 Q2 | 19.47 Billion JPY | 2.02% |
| 2015 Q3 | 20.75 Billion JPY | 6.56% |
| 2015 FY | 81.6 Billion JPY | -1.5% |
| 2015 Q1 | 19.09 Billion JPY | -14.29% |
| 2015 Q4 | 22.28 Billion JPY | 7.34% |
| 2014 FY | 82.85 Billion JPY | 23.31% |
| 2014 Q2 | 19.78 Billion JPY | -0.28% |
| 2014 Q3 | 20.95 Billion JPY | 5.94% |
| 2014 Q4 | 22.27 Billion JPY | 6.28% |
| 2014 Q1 | 19.83 Billion JPY | 7.04% |
| 2013 Q1 | 15.95 Billion JPY | -2.76% |
| 2013 FY | 67.19 Billion JPY | 5.17% |
| 2013 Q4 | 18.53 Billion JPY | 9.93% |
| 2013 Q3 | 16.86 Billion JPY | 6.45% |
| 2013 Q2 | 15.83 Billion JPY | -0.74% |
| 2012 Q4 | 16.41 Billion JPY | 4.38% |
| 2012 Q2 | 15.74 Billion JPY | -1.71% |
| 2012 Q1 | 16.01 Billion JPY | 1.82% |
| 2012 FY | 63.88 Billion JPY | 6.45% |
| 2012 Q3 | 15.72 Billion JPY | -0.12% |
| 2011 Q4 | 15.72 Billion JPY | 6.16% |
| 2011 FY | 60.01 Billion JPY | 3.5% |
| 2011 Q2 | 14.73 Billion JPY | -0.02% |
| 2011 Q1 | 14.74 Billion JPY | -4.72% |
| 2011 Q3 | 14.81 Billion JPY | 0.53% |
| 2010 FY | 57.98 Billion JPY | 3.79% |
| 2010 Q3 | 14.05 Billion JPY | -1.66% |
| 2010 Q2 | 14.29 Billion JPY | 0.29% |
| 2010 Q4 | 15.47 Billion JPY | 10.06% |
| 2010 Q1 | 14.25 Billion JPY | 8.74% |
| 2009 Q4 | 13.1 Billion JPY | -5.11% |
| 2009 Q2 | 14.53 Billion JPY | 0.0% |
| 2009 FY | 55.87 Billion JPY | 11.09% |
| 2009 Q3 | 13.81 Billion JPY | -4.97% |
| 2008 FY | 50.29 Billion JPY | 12.19% |
| 2007 FY | 44.82 Billion JPY | 10.89% |
| 2006 FY | 40.42 Billion JPY | 15.41% |
| 2005 FY | 35.02 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | -5731519.197% |
| Ansell Limited | 495.5 Million USD | -33021.09% |
| Ansell Limited | 495.5 Million USD | -33021.09% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | -198097.462% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -9482172.487% |
| Psykey, Inc. | 1.21 Million USD | -13524226.73% |
| ConvaTec Group Plc | 910.31 Million USD | -17928.359% |
| ConvaTec Group Plc | 872.5 Million USD | -18709.742% |
| Encision Inc. | 3.77 Million USD | -4345308.546% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -115727875.968% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -149288999.526% |
| Innovative MedTech Inc. | 6.09 Million USD | -2690750.518% |
| LifePoint, Inc. | 7.42 Million USD | -2210539.464% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | -2584795.259% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -19194636.842% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -22601100.329% |
| Reflect Scientific, Inc. | 1.06 Million USD | -15428606.805% |
| SmileDirectClub, Inc. | 517 Million USD | -31643.53% |
| Sector 10, Inc. | 39.84 Thousand USD | -411893786.156% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | -2370.483% |
| SheerVision, Inc. | 2.33 Million USD | -7038523.112% |
| United Health Products, Inc. | 2.42 Million USD | -6763236.588% |
| Vasamed, Inc. | 4.67 Million USD | -3511948.371% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | -6406127.799% |
| Yubo International Biotech Limited | 1.25 Million USD | -13046903.876% |